{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:18:57Z","timestamp":1785323937679,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00417-020-04767-9","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:47:35Z","timestamp":1591058855000},"page":"1579-1586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Medical management of pediatric glaucoma: lessons learned from randomized clinical trials"],"prefix":"10.1007","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-3140","authenticated-orcid":false,"given":"Matteo","family":"Sacchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario Alfio Umberto","family":"Lizzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Monsellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lucentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Luccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Serafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"5","key":"4767_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICU.0000000000000516","volume":"29","author":"A Thau","year":"2018","unstructured":"Thau A, Lloyd M, Freedman S, Beck A, Grajewski A, Levin AV (2018) New classification system for pediatric glaucoma: implications for clinical care and a research registry. Curr Opin Ophthalmol 29(5):385\u2013394","journal-title":"Curr Opin Ophthalmol"},{"key":"4767_CR2","first-page":"1162","volume":"122","author":"CY Qiao","year":"2009","unstructured":"Qiao CY, Wang LH, Tang X et al (2009) Epidemiology of hospitalized pediatric glaucoma patients in Beijing Tongren Hospital. Chin Med J 122:1162\u20131166","journal-title":"Chin Med J"},{"key":"4767_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1091-8531(99)70028-5","volume":"3","author":"RH Taylor","year":"1999","unstructured":"Taylor RH, Ainsworth JR, Evans AR, Levin AV (1999) The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS 3:308\u2013315","journal-title":"J AAPOS"},{"issue":"3","key":"4767_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/aos.13631","volume":"96","author":"K de Verdier","year":"2018","unstructured":"de Verdier K, Ulla E, L\u00f6fgren S, Fernell E (2018) Children with blindness\u2014major causes, developmental outcomes and implications for habilitation and educational support: a two-decade, Swedish population-based study. Acta Ophthalmol 96(3):295\u2013300","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"4767_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s12098-017-2405-2","volume":"84","author":"VSM Gudlavalleti","year":"2017","unstructured":"Gudlavalleti VSM (2017) Magnitude and temporal trends in Avoidable Blindness in Children (ABC) in India. Indian J Pediatr 84(12):924\u2013929","journal-title":"Indian J Pediatr"},{"key":"4767_CR6","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1167\/iovs.06-1350","volume":"48","author":"M Papadopoulos","year":"2007","unstructured":"Papadopoulos M, Cable N, Rahi J, Khaw PT, the BIG Eye Study Investigators (2007) The British Infantile and Childhood Glaucoma (BIG) Eye Study. Invest Ophthalmol Vis Sci 48:4100\u20134106","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4767_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701\u2013713","journal-title":"Arch Ophthalmol"},{"key":"4767_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M (2002) Early manifest glaucoma trial group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268\u20131279","journal-title":"Arch Ophthalmol"},{"key":"4767_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429\u2013440","journal-title":"Am J Ophthalmol"},{"key":"4767_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archophthalmol.2010.196","volume":"128","author":"BC Chauhan","year":"2010","unstructured":"Chauhan BC, Mikelberg FS, Artes PH, Balazsi AG, LeBlanc RP, Lesk MR et al (2010) Canadian glaucoma study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol 128:1249\u20131255","journal-title":"Arch Ophthalmol"},{"key":"4767_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487\u2013497","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"4767_CR12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"R van der Valk","year":"2005","unstructured":"van der Valk R, Webers CA, Schouten JS et al (2005) Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 112(7):1177\u20131185","journal-title":"Ophthalmology"},{"issue":"9","key":"4767_CR13","doi-asserted-by":"publisher","first-page":"e45079","DOI":"10.1371\/journal.pone.0045079","volume":"7","author":"JW Cheng","year":"2012","unstructured":"Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL (2012) Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS One 7(9):e45079","journal-title":"PLoS One"},{"key":"4767_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaapos.2009.10.003","volume":"13","author":"AC Black","year":"2009","unstructured":"Black AC, Jones S, Yanovitch TL et al (2009) Latanoprost in pediatric glaucoma\u2014pediatric exposure over a decade. J AAPOS 13:558\u2013562","journal-title":"J AAPOS"},{"key":"4767_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1091-8531(99)70092-3","volume":"3","author":"LB Enyedi","year":"1999","unstructured":"Enyedi LB, Freedman SF, Buckley EG (1999) The effectiveness of latanoprost for the treatment of pediatric glaucoma. J AAPOS 3:33\u201339","journal-title":"J AAPOS"},{"issue":"Suppl","key":"4767_CR16","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/S0039-6257(02)00303-X","volume":"47","author":"LB Enyedi","year":"2002","unstructured":"Enyedi LB, Freedman SF (2002) Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol 47(Suppl):S129\u2013S132","journal-title":"Surv Ophthalmol"},{"key":"4767_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0002-9394(98)00129-9","volume":"126","author":"CB Yang","year":"1998","unstructured":"Yang CB, Freedman SF, Myers JS et al (1998) Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome. Am J Ophthalmol 126:600\u2013602","journal-title":"Am J Ophthalmol"},{"key":"4767_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00061198-199906000-00009","volume":"8","author":"JC Altuna","year":"1999","unstructured":"Altuna JC, Greenfield DS, Wand M et al (1999) Latanoprost in glaucoma associated with Sturge-Weber syndrome: benefits and side-effects. J Glaucoma 8:199\u2013203","journal-title":"J Glaucoma"},{"key":"4767_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/bjo.87.9.1091","volume":"87","author":"T Ong","year":"2005","unstructured":"Ong T, Chia A, Nischal KK (2005) Latanoprost in port wine stain related paediatric glaucoma. Br J Ophthalmol 87:1091\u20131093","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"4767_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/IJG.0000000000001038","volume":"27","author":"L Quaranta","year":"2018","unstructured":"Quaranta L, Biagioli E, Riva I, Galli F, Poli D, Rulli E, Katsanos A, Longo A, Uva MG, Oddone F, Torri V, Weinreb RN (2018) The Glaucoma Italian Pediatric Study (GIPSy): 3-year results. J Glaucoma 27(10):856\u2013863","journal-title":"J Glaucoma"},{"key":"4767_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08820539709059808","volume":"12","author":"EK Donohue","year":"1997","unstructured":"Donohue EK, Wilensky JT (1997) Dorzolamide: a review. Semin Ophthalmol 12:119\u2013126","journal-title":"Semin Ophthalmol"},{"key":"4767_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1091-8531(98)90109-4","volume":"2","author":"M Portellos","year":"1998","unstructured":"Portellos M, Buckley EG, Freedman SF (1998) Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 2:43\u201347","journal-title":"J AAPOS"},{"key":"4767_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00061198-199602000-00012","volume":"5","author":"EK Donohue","year":"1996","unstructured":"Donohue EK, Wilensky JT (1996) Therapeutics and techniques: Trusopt, a topical carbonic anhydrase inhibitor. J Glaucoma 5:68\u201374","journal-title":"J Glaucoma"},{"key":"4767_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0161-6420(81)35055-6","volume":"88","author":"WP Boger","year":"1981","unstructured":"Boger WP, Walton DS (1981) Timolol in uncontrolled childhood glaucomas. Ophthalmology 88:253\u2013258","journal-title":"Ophthalmology"},{"key":"4767_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0161-6420(81)35043-X","volume":"88","author":"CD McMahon","year":"1981","unstructured":"McMahon CD, Hetherington J Jr, Hoskins HD Jr, Shaffer RN (1981) Timolol and pediatric glaucomas. Ophthalmology 88:249\u2013252","journal-title":"Ophthalmology"},{"key":"4767_CR26","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/archopht.1985.01050080075024","volume":"103","author":"HD Hoskins Jr","year":"1985","unstructured":"Hoskins HD Jr, Hetherington J Jr, Magee SD et al (1985) Clinical experience with timolol in childhood glaucoma. Arch Ophthalmol 103:1163\u20131165","journal-title":"Arch Ophthalmol"},{"key":"4767_CR27","first-page":"1","volume":"7","author":"EM Kanner","year":"2008","unstructured":"Kanner EM, Netland PA (2008) Medical therapy of pediatric glaucoma. Contemp Ophthalmol 7:1\u20138","journal-title":"Contemp Ophthalmol"},{"issue":"9","key":"4767_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1001\/archopht.123.9.1177","volume":"123","author":"EZ Ott","year":"2005","unstructured":"Ott EZ, Mills MD, Arango S et al (2005) Pediatric Dorzolamide Study Group. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years. Arch Ophthalmol 123(9):1177\u20131186","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"4767_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jaapos.2007.11.004","volume":"12","author":"JT Whitson","year":"2008","unstructured":"Whitson JT, Roarty JD, Vijaya L et al (2008) Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial. J AAPOS 12(3):239\u201346.e3","journal-title":"J AAPOS"},{"issue":"4","key":"4767_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jaapos.2009.04.017","volume":"13","author":"DA Plager","year":"2009","unstructured":"Plager DA, Whitson JT, Netland PA et al (2009) BETOPTIC S Pediatric Study Group. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial. J AAPOS 13(4):384\u2013390","journal-title":"J AAPOS"},{"issue":"10","key":"4767_CR31","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ophtha.2011.03.010","volume":"118","author":"T Maeda-Chubachi","year":"2011","unstructured":"Maeda-Chubachi T, Chi-Burris K, Simons BD et al (2011) A6111137 Study Group. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study. Ophthalmology 118(10):2014\u20132021","journal-title":"Ophthalmology"},{"issue":"5","key":"4767_CR32","first-page":"370","volume":"21","author":"ER Dixon","year":"2007","unstructured":"Dixon ER, Landry T, Venkataraman S, Gustafson N, Salem C, Bradfield Y, Aljasim LA, Feldman R (2007) A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension. JAAPOS 21(5):370\u2013374","journal-title":"JAAPOS"},{"issue":"1","key":"4767_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","volume":"123","author":"T Li","year":"2016","unstructured":"Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K (2016) Comparative Effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123(1):129\u2013140","journal-title":"Ophthalmology"},{"issue":"8","key":"4767_CR34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/IJG.0b013e31824d1e2f","volume":"22","author":"L Chang","year":"2013","unstructured":"Chang L, Ong EL, Bunce C, Brookes J, Papadopoulos M, Khaw PT (2013) A review of the medical treatment of pediatric glaucomas at Moorfields Eye Hospital. J Glaucoma 22(8):601\u2013607","journal-title":"J Glaucoma"},{"key":"4767_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.icu.0000193091.60185.27","volume":"17","author":"SA Tanimoto","year":"2006","unstructured":"Tanimoto SA, Brandt JD (2006) Options in pediatric glaucoma after angle surgery has failed. Curr Opin Ophthalmol 17:132\u2013137","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"4767_CR36","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.ophtha.2012.02.030","volume":"119","author":"JA Cook","year":"2012","unstructured":"Cook JA, Botello AP, Elders A, Fathi Ali A, Azuara-Blanco A, Fraser C, McCormack K, Margaret Burr J, Surveillance of Ocular Hypertension Study Group (2012) Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 119(8):1552\u20131557","journal-title":"Ophthalmology"},{"issue":"6","key":"4767_CR37","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00417-002-0462-2","volume":"240","author":"JM Korte","year":"2002","unstructured":"Korte JM, Kaila T, Saari KM (2002) Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol 240(6):430\u2013435","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"4767_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0161-6420(84)34141-0","volume":"91","author":"MS Passo","year":"1984","unstructured":"Passo MS, Palmer EA, Van Buskirk EM (1984) Plasma timolol in glaucoma patients. Ophthalmology 91(11):1361\u20131363","journal-title":"Ophthalmology"},{"issue":"10","key":"4767_CR39","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/sj.eye.6702850","volume":"21","author":"M Papadopoulos","year":"2007","unstructured":"Papadopoulos M, Khaw PT (2007) Advances in the management of paediatric glaucoma. Eye 21(10):1319\u20131325","journal-title":"Eye"},{"key":"4767_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajo.2018.08.039","volume":"196","author":"M Younus","year":"2018","unstructured":"Younus M, Schachar RA, Zhang M, Sultan MB, Tressler CS, Huang K, Xu W, Klein M, Platt RW, Mukherjee N, Haenel E, Freedman SF (2018) A long-term safety study of latanoprost in pediatric patients with glaucoma and ocular hypertension: a prospective cohort study. Am J Ophthalmol 196:101\u2013111","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04767-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:19:43Z","timestamp":1622593183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4767"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04767-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}